Catalog name Description price
R-XASYS-00699 AS-1269574,cas:330981-72-1 AS1269574 is a potent, orally available GPR119 agonist, with an EC50 of 2.5 μM in HEK293 cells expressing human GPR119. AS1269574 activates TRPA1 cation channels to stimulate glucagon-like peptide-1 (GLP-1) secretion. AS1269574 specifically induces glucose-dependent insulin secretion from pancreatic β-cells only under high-glucose conditions. price>
R-XASYS-00700 Asapiprant,cas:932372-01-5 Asapiprant(C24H27N3O7S,501.6) is a potent and selective DP1 receptor antagonist with a Ki of 0.44 nM. price>
R-XASYS-00701 Asenapine hydrochloride,cas:1412458-61-7 Asenapine hydrochloride(C17H17Cl2NO,322.23), an antipsychotic, is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and Dopamine (D2, D3, D4) receptor antagonist with Ki values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor, respectively. price>
R-XASYS-00702 ASP-9521,cas:1126084-37-4 ASP-9521(C19H26N2O3,330.42) is a potent, selective and orally available AKR1C3 inhibitor with an IC50 of 11 nM for human AKR1C3. price>
R-XASYS-00703 Asp-AMS,cas:828288-98-8 Asp-AMS(C14H19N7O9S,461.41), an analogue of aspartyl-adenylate, is an aspartyl-tRNA synthetase inhibitor and also a strong competitive inhibitor of the mitochondrial enzyme. price>
R-XASYS-00704 ASP5878,cas:1453208-66-6 ASP5878(C18H19F2N5O4,407.37) is an oral active inhibitor of FGFR 1, 2, 3, and 4, with IC50 values of 0.47 nM, 0.6 nM, 0.74 nM and 3.5 nM for FGFR 1, 2, 3, and 4 kinase activity. ASP5878 has potential antineoplastic activity. price>
R-XASYS-00705 Aspartyl-alanyl-diketopiperazine,cas:110954-19-3 Aspartyl-alanyl-diketopiperazine (C7H10N2O4,186.17) is an immunomodulatory molecule generated by cleavage and cyclization from the N-terminus of human albumin and can modulate the inflammatory immune response through a molecular pathway implicated in T- lymphocyte anergy. price>
R-XASYS-00706 Aspirin Aluminum,cas:23413-80-1 Aspirin Aluminum(C18H15AlO9CAS,402.3) is a novel intermolecular compound which can inhibit gastrointestinal mucosal disorders induced by NSAIDs (non-steroidal anti-inflammatory agents) extracted from patent WO 2010064441 A1. price>
R-XASYS-00707 ASTX660,cas:1799328-86-1 ASTX660(C30H42FN5O3,539.7) is an orally bioavailable dual antagonist of cellular inhibitor of apoptosis protein (cIAP) and X-linked inhibitor of apoptosis protein (XIAP) price>
R-XASYS-00708 AT-13387,cas:912999-49-6 AT-13387(C24H31N3O3,409.5) is a synthetic small molecule that has been developed as a potential therapeutic agent for the treatment of cancer. It is a member of the family of histone deacetylase (HDAC) inhibitors, which are drugs that target the epigenetic machinery of cells and have been used in the treatment of various types of cancer. price>